Search results for: “vaccine”
-
EKF and Kantaro partner to market COVID antibody testing in UK and Europe
•
LONDON: EKF Diagnostics Holdings announced a two year marketing and distribution agreement with Kantaro Biosciences LLC. EKF will…
-
Open Orphan signs contract with UK government to develop COVID-19 human challenge study model
•
LONDON: Open Orphan plc (ORPH) announced the signing of a contract by hVIVO, a subsidiary of Open Orphan,…
-
Ryanair announces to cut winter capacity from 60% to 40%
•
LONDON, UK: Ryanair, Europe’s largest airline, today further reduced its winter schedule (Nov – Mar) taking capacity down…
-
Brent MacGregor appointed CEO of Medical Developments International Limited
•
MELBOURNE: Medical Developments International Limited (MVP) announced the appointment of Brent MacGregor as Chief Executive Officer of the…
-
Oncimmune signs agreement with Cedars-Sinai to profile immune response to COVID-19
•
LONDON: Oncimmune Holdings plc has signed a commercial agreement with Cedars-Sinai, California, USA, to provide antibody profiling in…
-
AstraZeneca’s COVID-19 long-acting antibody combination advances into Phase III clinical trials
•
LONDON: AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than…
-
CSL Limited
•
CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets products to treat and…
-
Oncimmune announces UK Government funding for tool for use in COVID-19
•
LONDON: Oncimmune Holdings announced the award of funding from the ‘UK Research and Innovation (UKRI) Ideas to Address…
-
PCI Biotech forms research collaboration with DCprime
•
OSLO: PCI Biotech has announced an extensive research collaboration. Within the collaboration, DCprime and PCI Biotech will combine…
-
GlaxoSmithKline plc (GSK)
•
GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in Brentford, England. Established in 2000, by a…
-
AstraZeneca announces a three-tranche $3 billion global bond offering
•
LONDON: AstraZeneca PLC announces that, on 3 August 2020, it priced a three tranche global bond offering totalling…
-
COVID-19: Pfizer and BioNTech commence pivotal Phase 2/3 global study
•
NEW YORK: Pfizer Inc. and BioNTech SE announced the start of a global (except for China) Phase 2/3…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.